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Introduction
Microarray gene expression profiling has become a widely used tool to identify particular disease subpopulations and to perform diagnostic and prognostic predictions (1, 2, 4, 8, 9, 10, 18) . Typically the primary goal is to construct a predictor based on the measured gene expression data set, such that the outcome (e.g. prognosis, disease type) on unseen cases can be predicted as accurately as possible. Since this prediction becomes, in general, more reliable if only a subset of the complete set of measured genes is employed by the predictor, a by-product of this process is a genetic profile (a set of marker genes) associated with the prediction problem.
The methodology for constructing a prediction rule based on microarray data involves several steps. These include selection of a quality filtered gene set, choosing a predictor (classifier), selection of the reporter genes in the final profile and independent validation of the rule.
Many different variations on this basic methodology have been proposed, mostly involving different combinations of reporter selection strategies and predictors. Dudoit et al. (26) compared different predictors and concluded that simple predictors, such as the diagonal linear discriminant classifier (DLDC) perform well on gene expression datasets. Recently, Romualdi et al. (27) performed a comparison of predictors and dimensionality reduction techniques, with an emphasis on investigating the effect of certain experimental variables in a multi-class setting. Li et al. (28) also compared predictors in multi-class problems, with an emphasis on issues relating to the combination of binary classifiers in multi-class settings.
Inza et al. (32) compared filter and wrapper reporter selection strategies on two gene expression datasets.
Here we review the basic methodology (from normalized array data to the final predictor) and evaluate the merits of the possible choices in each step. We investigate different types of predictors, chosen to cover a range of predictor types and to be representative of earlier employed rules. We also evaluate different strategies for selecting the reporters for the final profile. We compare different predictor-selector combinations on six gene expression datasets with varying degrees of difficulty in predictability: Breast cancer metastasis (1, 2) , Colon cancer (3), Leukemia (4), Diffuse-large-B-cell-lymphoma (5), Prostate cancer (6) , and Central nervous system embryonic treatment outcome (7) . This study shows that 'simple' predictors (e.g. the nearest mean classifier) and simple reporter selection strategies (forward filtering) perform above expectation, while forward filtering outperforms partial least squares as dimensionality reduction algorithm.
An important contribution of this work is the description of a training and validation protocol, which allows objective evaluation of the complete methodology for constructing a predictor.
Since the protocol reduces the effect of variance in the performance estimates and completely decouples the training from the validation steps, more reliable performance estimates are obtained. Consequently the protocol is a useful tool to evaluate different configurations of reporter selectors and predictors, and to determine whether a given novel methodology truly improves on existing cutting-edge approaches.
Methods
In this section we outline the basic predictor construction methodology, which inputs a gene expression dataset and outputs a trained prediction rule. This rule predicts the relevant outcome based on a specified set of genes (reporters).
Most approaches follow the same basic steps, namely 1) reducing the initial complete set (tens of thousands) of genes to a smaller quality filtered set of genes (thousands); 2) selecting a suitable prediction rule and reporter selection algorithm; 3) training the rule, i.e. selecting the optimal set of reporters and tuning the parameters in the prediction rule itself; 4) estimating the expected generalization performance of the rule; 5) constructing the final predictor, and 6) validating the performance of the final predictor on an independent validation series.
Quality filtering. The first step involves the reduction of the number of genes from the number on the array (tens of thousands) to several thousand. Often, heuristic approaches are followed by selecting genes with an N-fold variation (ratio of maximal and minimal expression) and an absolute difference (difference of maximal and minimal expression) which exceeds a given threshold.
Quality filtering should ideally be performed based on the quality of the measurements, as expressed objectively in an error model (12) . Such an error model provides p-values expressing the evidence that a particular gene is expressed differentially with respect to the control (employing the measurement error as yardstick). Consequently, genes are included that have been present (p<pmin) in at least Nmin tumors. This is a one-time selection, which is performed prior to reporter selection and predictor training, and is not repeated during later steps. Note that this step eliminates genes purely based on the quality of the measurement -it does not employ any information related to the outcome.
Predictor selection. In molecular classification we are faced with a situation where the number of samples (arrays), n, is much smaller than the number of genes, p. Since perfect prediction of the outcome for the arrays in the training set is likely to occur when employing all genes, care must be taken not to over-train the predictor. An over-trained predictor predicts the outcome of the training set systematically better than the outcome of unseen arrays. Several measures, such as the application of cross-validation during training, and the reduction of the set of reporters through unbiased reporter selection can be taken to prevent over-training. (See the next section). Choosing a predictor with limited complexity also constrains the training process and is therefore an important tool to prevent over-training and ensure robust prediction.
For our study, predictors were selected based on their low complexity and/or the fact that these predictors were successfully applied in published studies. We also strived for a combination of nonlinear and linear predictors. In addition, all selected methods can be employed when p>n. We have included the following predictors:
1) The nearest mean classifier (NMC) with cosine correlation as distance measure, previously employed on gene expression data in (1); 2) Diagonal Linear Discriminant Classifier (DLDC) (26) . The expression ratios within the classes are assumed to be similarly distributed around the class means. The DLDC is, together with the NMC, the predictors with the lowest complexity;
3) Simple Bayes Gaussian Classifier (SBGC) (13, 26) , also referred to as a Quadratic linear discriminant, is a quadratic predictor, with a higher complexity than the NMC and DLDC predictors. This predictor is based on the assumption that the genes are independent and that the distribution of the expression ratios within each of the classes can be modeled by a Gaussian distribution. It was applied to molecular data by Dudoit et al. (26) and Wessels et al. (21) .; 4) K-nearest neighbor predictor (k-NN) (14) . This predictor is a very simple, intuitive predictor frequently included in gene expression analyses (26, 15) . By varying the value of k, i.e. the number of neighbors employed to determine the class label of a new array, more robustness against noise can be introduced. In this study we varied k across the following values: k {1,5,9}. (27) showed that a dimensionality reduction method known as partial-least-squares (PLS) -which was first applied to gene expression data by Nguyen and Rocke (19) -had either no effect or improved predictor performance on some datasets. For this reason we include this dimensionality reduction method in this study. However, it should immediately be noted that these methods do not reduce the number of reporter genes that will be employed in the final predictor. This has obvious drawbacks in cases where a custom diagnostic array should be designed containing only the marker genes required for correct classification.
Techniques that explicitly select a subset of reporter genes, typically do so by searching for a set of reporter genes that optimize a given criterion. In the machine learning community a distinction is frequently made between filter and wrapper approaches (20) . Wrapper approaches explicitly employ the prediction rule to determine the order in which a gene is added to the selected reporter set. Filter approaches, on the other hand, employ a criterion separate from the prediction rule to determine the order in which genes are added. Feature selection strategies can also be distinguished based on the direction of the search. Forward selection strategies start with an empty set and add reporters until no improvement in prediction performance results; backward selection starts with the complete set of genes and removes reporters until the prediction performance starts decreasing. In earlier studies (21, 22) is was found that, in general, forward filter approaches performed at least as good, and frequently even better, than forward wrapper approaches employing a greedy forward selection strategy. In addition, wrapper approaches are computationally far more expensive.
Therefore, we will not include forward wrapper approaches in this study.
Forward filtering involves two steps. First the reporters are ranked based on their capability to separate the outcome groups (classes). Then, starting with the best gene (largest separation between classes), the set of chosen reporters is expanded by adding the next best reporter.
Each time a gene is added, the classification performance of the selected set of reporters is estimated by computing the cross-validation performance of a predictor employing these reporters. This process of adding a gene and testing is terminated when the cross-validation performance reaches a maximum.
In order to perform filtering, a ranking criterion needs to be selected. Several criteria can be employed for continuous valued data, such as signal-to-noise ratio (SNR), t-test, ManWhitney u-test and Mahalanobis distance. In our experience (data not shown) these measures perform very similarly and therefore the choice of ranking criterion is not critical.
We have chosen the SNR as univariate ranking criterion for its simplicity, which has the added benefit of considerable computational speed-up. Unlike the other methods, it does not vary systematically with sample size, which may also be regarded as an advantage.
Two backward selection approaches are included. These were selected since these approaches were, apart from forward filtering and wrapping, the most frequently employed reporter selection approaches. There approaches are: 1) Recursive Feature elimination (RFE) (23) and 2) Shrunken centroids (SC) (11) . Strictly speaking, SC is usually performed in a backward fashion, i.e. gradually removing genes, but it could also be performed in a forward fashion, since the direction does not influence the course of the search. In contrast to the filter and wrapper approaches where the predictor and selection procedure can be independently selected, RFE and SC represent cases where the predictor and the selection algorithm are tightly integrated. RFE is a selection method designed to operate in conjunction with the support vector machine (SVM). A SVM is trained on the complete set of genes and assigns a weight to each gene. Only those genes with the largest absolute weights are retained for the next iteration. Typically, only half of the genes are retained. The crossvalidation performance of every reporter set is registered at every elimination step. The process of training and removal is repeated on the remaining genes until the performance drops or a single gene is retained. Shrunken centroids assigns a univariate distance score to every gene, which reflects the capacity of that gene to separate the classes in the dataset.
This distance is gradually shrunk (reduced) to zero, and at every shrinkage step a linear predictor is constructed based on the shrunken centroids (class means reconstructed based on the shrunken distance scores). The cross-validation performance of this predictor is employed as measure of the quality of the set of reporters employed. When a distance becomes zero for a particular gene, that gene does not participate in the prediction, and is removed from the reporter set. The shrinkage process stops when the performance reaches a maximum or when all genes have been shrunk away.
All the predictors discussed in the section entitled 'Predictor selection', were employed in conjunction with 1) filtering as reporter selection algorithm with SNR as ranking criterion and
2) PLS as a dimensionality reduction algorithm. In addition, the linSVC-RFE-combination and SC were included as instances of integrated selector-predictor approaches.
Training-validation protocol.
A frequently employed approach during predictor construction is to split the available samples in a training set and a validation set. Various rules are maintained for the sizes of these sets. The training set is employed to construct a predictor, and the validation set is employed to estimate the performance of the predictor on unseen samples. However, depending on the particular way in which the dataset is split Cross-validation is a powerful, frequently employed tool to train predictors and estimate the generalization performance (performance on unseen cases). It is generally accepted (24) that leave-one-out-cross-validation (LOOCV) is unbiased with respect to the training set, but highly variable (30) . Ten-fold cross-validation (10FCV) -which leaves out 10% of the datais, on the other hand more biased, but has lower variance. Based on this fact, as well as empirical evidence (albeit in p < n settings) (20) 10FCV is frequently the method of choice.
Here we employ a smaller fold, since a larger proportion of the data set is available for testing, resulting in more reliable estimates of differences between different approaches.
More specifically, we employ three-fold cross-validation (3FCV) in the outer or validation loop to have a larger proportion of the data for validation (See also (26)), and we employ 10FCV
in the inner or training loop, since a larger proportion of the data is then employed to optimize the predictor.
The cross-validation error rate is employed to guide the training process. Often, the total error rate is employed, which is the sum of the false negatives (FN) and false positives (FP).
In microarray datasets, the positive class (tumor vs. normal tissue, recurrence vs. no recurrence) frequently consists of fewer samples than the negative class. It is often desirable to identify the positive cases as accurately as possible. Under these conditions, the total error rate has the disadvantage that a predictor which always guesses the majority class will achieve a low total error rate, while it is, in fact, misclassifying all the positive cases. For this reason, we employ the 'average-true-positive-true-negative-performance' which is given by (TP/P +TN/N)/2, with TP, TN, P and N denoting true positives, true negatives, number of positives and number of negatives, respectively. In diagnostic terms, this is the average of sensitivity and specificity.
A training protocol delivers, given a training data set, a trained predictor and an estimate of the performance of this predictor on unseen data. We therefore split the training-validation protocol in two parts: a training procedure and a validation step. Figure 1 provides a simplified schematic overview of the complete protocol. The first step is to split the data set, X, in a training and validation set. When N-fold cross-validation is employed in the outer loop, the dataset is split in N folds. During one cross-validation iteration, all folds but fold j is employed as training set, denoted by X (-j) and fold j is employed as validation set, denoted by X (j) . Since we employ 3FCV for the outer loop, the dataset is split in three folds, or a ratio of 1:2. It is always ensured that each of the splits is properly stratified with respect to the classes in the dataset, i.e. that all classes are represented in the same ratios in each fold as they are represented in the complete dataset.
The purpose of the training procedure (Block 4 in Figure 1 ) is to set all parameters in a given predictor employing the training set. For example, for the nearest mean predictor and forward filtering as reported selector, the training procedure optimizes the number of reporters to employ and the values of the centroids given these reporters. We employ 10FCV to perform this optimization, i.e. we split the training set, X (-j), in ten different training-testfolds, determine the centroids and optimal reporter set on the training fold and estimate the performance on the test fold (Block 1 in Figure 1 ). At the end of a 10FCV run we have created ten predictors with their associated reporter sets. In Block 2, these ten predictors and reporter sets are combined into a single final predictor. The output of this combining process is an estimate of the optimal number of reporter genes to employ, n*, and the training performance, t j *. The final step of the training procedure is performed in Block 3, where the complete training set, X (j), and the optimal number of reporters, n*, is employed to train the final predictor, C n* . In summary, the training procedure inputs the training set and outputs the training performance and a trained predictor with the optimal parameter settings.
In the validation step, the final trained predictor, C n* , is validated on the validation set, X (j) In the cases they discuss, the bias is introduced as follows. The complete data set is employed to select a subset of reporter genes. Then the expected performance of the predictor with the selected subset of reporter genes is estimated in a cross-validation procedure. This cross-validation performance estimate is upwardly biased since the tumors present in the validation sets in each of the cross-validation folds were also employed to select the subset of genes. Since gene selection is part of the training process, this amounts to training on the validation set, hence the bias. This effect was also demonstrated for random datasets by Simon et al. (31) . The bias is removed by performing both the gene selection and predictor training only on the training set of a particular fold of the crossvalidation process. In our protocol, this ensures that the construction of the predictor is completely independent from the evaluation thereof in the cross-validation procedure.
Datasets
In this study, we revisit our published breast cancer series (1,2). We also selected five publicly available datasets, the Colon cancer(3), Leukemia(4), Diffuse large B-cell lymphoma (DLBCL) (5), prostate cancer (6) and central nervous system (CNS) (7) datasets. For the colon, leukemia, DLBCL and prostate cancer datasets, the purpose is to predict the disease/tissue type. For the breast cancer and CNS dataset, the purpose is to predict future events: whether metastasis will occur (breast cancer) and the effectiveness of treatment (CNS). The latter type of problem (outcome prediction) is, generally, significantly more difficult than type-prediction. This is also reflected in the performance levels typically achieved. For this reason, the selection of data sets provides a good test of different prediction methodologies. All datasets are two-class prediction problems, and the datasets and quality filtering strategies are described in detail in the supplementary information. Strictly speaking, parameters such as the value of k (number of neighbors) in the nearest neighbor predictor and in the RFLD should also be optimized in the training procedure, since a choice of these parameters based on the validation performance also introduces a slight bias. However, we have chosen to isolate these parameters in order to highlight their effect on the validation performance of the predictors. In general, this bias is much smaller than the bias which Ambroise and McLachlan (24) warn against.
Experiments

Results
The results of applying the training and validation protocol for the 22 selector-predictor combinations on the Breast cancer dataset are depicted in Table 1 from the best combination for a particular dataset across all 300 validation folds. Note that in each of the 300 trials a direct comparison can be made between the different combinations, since exactly the same samples were employed in each split for every classifier. The 'wondrawn-lost' representation provides additional information to interpret differences in average performance between two combinations. In the clinical setting, this has the following implication. Given two predictors, P a and P b , where P a is better than P b , it implies that if both predictors are employed to predict the disease state of a very large number of patients, the average performance of P a across all patients will exceed that of P b . However, it is quite possible that for some of these patients predictor P b will predict correctly, while P a is in error.
However, we expect P a to win a majority of the times. The 'won-drawn-lost ' decomposition helps to interpret the margin of difference between the average performances. For example, for the Breast cancer dataset ( On all the other datasets PLS causes a (in some cases dramatic) decrease in performance.
Why this happens is not completely clear at this stage. The performance of PLS does not seem to be correlated with the type of microarray employed to measure the data (one-color Affymetrix or two-color cDNA/oligo/Agilent) and will be a topic for further research. The experiments show, contrary to the results presented in Romualdi et al. (27) that PLS does not improve performance in general.
Training and validation performance. Inspection of the average training performance (T)
and average validation performance (V) in Table 1 for all the selector-predictor combinations reveals two striking characteristics in the data. (Similar characteristics are revealed in the results for the other datasets presented in the Supplementary information). First, the training and validation performance is well correlated. This is to be expected, since the training performance aims at producing a good predictor, therefore performance on the training data should be indicative of validation performance. Second, the average training set performance is generally an over-estimate of the final (most unbiased) validation set performance. This clearly indicates the benefit of adding an independent validation loop to the trainingvalidation protocol to remove any biases that may be present in the training performance.
Interestingly enough, this bias need not always be upward. When 2FCV is employed during the training phase, training performance underestimates the final validation performance (results not shown). This is probably caused by the fact that in 10FCV the training performance is based on the predictor extracted from 90% of the training set, while in 2FCV
it is based on 50% of the training set, leading to a lower performance. In contrast, the validation performance is based on the predictor extracted from the complete training set in both cases. Quite reassuring is the fact that the validation performances obtained when Global comparison. Table 3 contains a global summary of all the results contained in Tables 1 and Supplementary tables The last column indicates largest absolute performance difference across a row. Here DLDC has the lowest value, i.e. it performs consistently well, with SC and NMC slightly worse. With
Filter-NMC, Filter-DLDC and SC scoring well in terms of the average and maximal difference, these are the selector-predictor combinations of choice.
Discussion
In this paper we make a detailed proposal for a training-validation-protocol, which can be employed to create a predictor of outcome (e.g. disease state) based on a dataset consisting of a series of (gene) expression microarrays derived from a labeled set of exemplars, e.g.
tumor samples. The most important aspect of this protocol is that it ensures that all training steps, such as reporter set selection and optimization of the remaining parameters of the classifier are performed completely independently from the final validation step, where the performance of the predictor is estimated. This ensures that this performance estimate is not an upwardly biased (i.e. optimistic) estimate of the performance of the predictor. Another important characteristic of this protocol is that the steps of independent training and validation are repeated frequently, to overcome the sampling effects that are strongly present in microarray datasets. We advocate this approach over an approach where the dataset is split once in a training and validation set, and the performance on the validation set is employed as true performance estimate of the predictor trained on the training set.
This preference stems from the fact that the validation set is typically small (approximately 20% of the total data set) which increases the variability in the validation estimate (up to 50% performance differences), and could, therefore, in some cases result in an optimistic performance estimate. A validation set of substantial size (e.g. more than twice the training set size) obviously reduces the variance in the validation performance estimate. However, it suffers from the obvious drawback that the majority of the measured samples are not employed during the training process. In this study we proposed to use 3FCV in the outer validation loop. Leave-one-out cross-validation (LOOCV) is frequently employed in microarray studies, and could also be employed in the outer validation loop. LOOCV has the advantage that the performance estimates have a smaller bias, but suffer from larger variance (30) .
Results with LOOCV employed in the outer loop, for Filtering in combination with all predictors, indicated that the relative performances of the combinations remain largely the same, with a slight performance increase (~3%) on the Prostate and CNS datasets (results not shown). The classifiers that showed the least sensitivity to a change in the fold of the outer loop are also the best performing classifiers, namely the Filter-NMC and Filter-DLDC.
Similarly, experimental evidence not shown here, indicated that when we switched from 10FCV to 2FCV in the inner loop, no noticeable differences with respect to the validation performance as measured in the outer loop were observed. Nevertheless, in the case of 2FCV the choice of the number of reporters would be based on only 1/3 of the full sample and this might cause problems in the case of a small sample sizes. Employing 3FCV in the validation loop has the following advantages. In a comparative study it puts more emphasis on the differences between the performances of the predictors (See also Dudoit et al. (26) ).
In addition, many three-fold loops can be performed to overcome the sampling effects.
Finally, 3FCV has the advantage that a relatively large portion of the samples are set aside for testing during each loop, while the training set is remains relatively large. This results in conservative performance estimates and is preferable since one then errs on the side of caution.
Given such a training-validation protocol, it is possible to objectively evaluate different strategies for constructing predictors. The most important components of this multi-step strategy that were evaluated here are the types of reporter selectors and predictors being employed. Here we compared 22 selector-predictor combinations on six gene expression datasets. The most important conclusions are that PLS slightly improved the performance on two datasets (Leukemia when combined with any predictor and Prostate when combined with RFLD) while resulting in an often dramatic deterioration in performance on all the other datasets. Even in cases where PLS is the best dimensionality reduction technique, the number of genes required to make the final prediction is not reduced: in order to classify a new case, all genes need to be measured, and mapped to the optimal PLS subspace. From a cost perspective, this might be a drawback, since complex arrays are then required for diagnostic tests. Generally speaking, simple approaches performed very well. The best combinations are
Filter-NMC, Filter-DLDC and SC. This can be explained by the fact that these are known to be most tolerant to noisy measurements and to datasets with potentially many irrelevant features.
The results of two studies seem to contradict some of our own conclusions. Inza et al. (32) found that wrapper methods generally outperform filter methods, while Romualdi et al. (27) found that PLS resulted in a better performance of the classifier compared to PCA and shrunken centroids. One important difference between the current paper and the work of The second-to-last column contains the median validation performance difference across all datasets (median of that row). The top five average performances are shaded grey and the worst five are colored black. 
